HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
基本信息
- 批准号:6362916
- 负责人:
- 金额:$ 8.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-03-01 至 2004-02-29
- 项目状态:已结题
- 来源:
- 关键词:Candida albicans HIV infections antiAIDS agent antifungal agents binding proteins candidiasis complementary DNA computer assisted sequence analysis drug resistance fungal genetics fungal proteins gene expression genetic library human tissue laboratory rabbit mass spectrometry membrane potentials membrane transport proteins nucleic acid sequence opportunistic infections pathologic process polymerase chain reaction protein structure function saliva virulence
项目摘要
This is a new application for an Independent Scientist Award (K02) for Dr. Mira Edgerton, and it accompanies the already funded R01DE12159 grant. Dr. Edgerton has a D.D.S. degree, specialty training in prosthodontics, and a Ph.D. in Oral Biology. She is an Assistant Professor in the Departments of Restorative Dentistry and Oral Biology at the State University of New York at Buffalo (SUNYAB). Dr. Edgerton's research has focused on characterizing the structural elements of salivary histatins required for candidacidal activity as well as the cellular mechanism of action of histatins with Candida albicans. Her work has identified a C. albicans membrane protein (HstBP) which is a yeast receptor protein of the histatin candidacidal pathway. The current research project will clone and sequence the C. albicans HstBP gene and examine its expression as a virulence or resistance factor in yeast from HIV-oropharyngeal candidiasis patients. Dr. Edgerton's immediate goals are to use the most current techniques in yeast molecular genetic to identify mechanisms of C. albicans pathogenicity in the oral cavity. Her long range goals are to define the molecular basis of virulence, pathogenesis and drug resistance of C. albicans in order to develop better treatment modalities for local and systemic candidiasis. Achievement of these goals is possible only through acquisition of an in-depth background in yeast molecular genetics and knowledge of the most current systems fir eukaryotic genetics. Dr. Edgerton's scientific career would be advanced through this additional training and experience. The research environment in the Department of Oral Biology at SUNYAB in combination with experiences in the laboratories of other yeast molecular geneticists is excellent for development of the research career of Dr. Edgerton. However, her clinical teaching duties limit the time available to her for acquiring these additional research skills. This ISA application is to obtain salary support to release Dr. Edgerton from her clinical teaching and committee responsibilities in order to devote 80% of her full time professional effort to research activities. This award would provide her the opportunity to extend her background in yeast biology to the molecular level and apply this new expertise to studies of virulence and pathogenesis of oral and systemic candidiasis.
这是Mira埃杰顿博士独立科学家奖(K02)的新申请,它伴随着已经资助的R01DE 12159赠款。埃杰顿医生有糖尿病。学位,修复学专业培训,博士学位。口腔生物学她是布法罗纽约州立大学修复牙科和口腔生物学系的助理教授。埃杰顿博士的研究重点是表征杀念珠菌活性所需的唾液组胺素的结构要素,以及组胺素与白色念珠菌作用的细胞机制。她的工作已经确定了一个C。白色念珠菌膜蛋白(HstBP),其是组胺素杀念珠菌途径的酵母受体蛋白。目前的研究项目是克隆和测序C。白念珠菌HstBP基因,并检测其作为毒力或耐药因子在来自HIV口咽念珠菌病患者的酵母中的表达。埃杰顿博士的近期目标是利用酵母分子遗传学中最新的技术来确定C。白色念珠菌在口腔中的致病性。她的长期目标是确定C.白色念珠菌,以开发更好的治疗局部和系统性念珠菌病的方式。这些目标的实现是可能的,只有通过收购在酵母分子遗传学和最新的系统fir真核遗传学知识的深入背景。埃杰顿博士的科学生涯将通过这一额外的培训和经验。SUNYAB口腔生物学系的研究环境与其他酵母分子遗传学家实验室的经验相结合,对埃杰顿博士的研究事业发展非常有利。然而,她的临床教学职责限制了她获得这些额外研究技能的时间。该伊萨申请是为了获得工资支持,以释放埃杰顿博士从她的临床教学和委员会的责任,以投入她的全职专业工作的80%的研究活动。该奖项将为她提供机会,将她的酵母生物学背景扩展到分子水平,并将这种新的专业知识应用于口腔和系统性念珠菌病的毒力和发病机制的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mira Edgerton其他文献
Mira Edgerton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mira Edgerton', 18)}}的其他基金
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
白色念珠菌口腔感染塑造先天免疫和骨髓源性抑制细胞的募集
- 批准号:
10501899 - 财政年份:2022
- 资助金额:
$ 8.36万 - 项目类别:
Candida albicans oral infection shapes innate immunity and recruitment of myeloid-derived suppressor cells
白色念珠菌口腔感染塑造先天免疫和骨髓源性抑制细胞的招募
- 批准号:
10665797 - 财政年份:2022
- 资助金额:
$ 8.36万 - 项目类别:
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
白色念珠菌分泌的蛋白酶 Sap6 与上皮蛋白酶激活受体 PAR2 和 NLRP3 结合
- 批准号:
10428637 - 财政年份:2021
- 资助金额:
$ 8.36万 - 项目类别:
Candida albicans secreted protease Sap6 engages epithelial protease-activated receptors PAR2 and NLRP3
白色念珠菌分泌的蛋白酶 Sap6 与上皮蛋白酶激活受体 PAR2 和 NLRP3 结合
- 批准号:
10300121 - 财政年份:2021
- 资助金额:
$ 8.36万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2449485 - 财政年份:1999
- 资助金额:
$ 8.36万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6164397 - 财政年份:1999
- 资助金额:
$ 8.36万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6516337 - 财政年份:1999
- 资助金额:
$ 8.36万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
6634566 - 财政年份:1999
- 资助金额:
$ 8.36万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2015439 - 财政年份:1997
- 资助金额:
$ 8.36万 - 项目类别:
HISTATIN RECEPTORS AS DRUG TARGETS FOR ORAL CANDIDIASIS
组氨酸受体作为口腔念珠菌病的药物靶点
- 批准号:
2856658 - 财政年份:1997
- 资助金额:
$ 8.36万 - 项目类别:
相似海外基金
A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
- 批准号:
MR/V035304/1 - 财政年份:2022
- 资助金额:
$ 8.36万 - 项目类别:
Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
- 批准号:
10369859 - 财政年份:2021
- 资助金额:
$ 8.36万 - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10461964 - 财政年份:2021
- 资助金额:
$ 8.36万 - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10326617 - 财政年份:2021
- 资助金额:
$ 8.36万 - 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
- 批准号:
404211 - 财政年份:2018
- 资助金额:
$ 8.36万 - 项目类别:
Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
- 批准号:
9078083 - 财政年份:2015
- 资助金额:
$ 8.36万 - 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
- 批准号:
9079323 - 财政年份:2015
- 资助金额:
$ 8.36万 - 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
- 批准号:
9079336 - 财政年份:2015
- 资助金额:
$ 8.36万 - 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
- 批准号:
8472130 - 财政年份:2012
- 资助金额:
$ 8.36万 - 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
- 批准号:
8532661 - 财政年份:2011
- 资助金额:
$ 8.36万 - 项目类别: